Translation of an allogenic tissue engineering product with mesenchymal stromal cells from Wharton’s jelly for the treatment of osteonecrosis in paediatric oncology patients
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
